Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.

导出 LinkOut

翻译打印收藏纠错

第一作者： Vikram,Kaithwas

第一单位： Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sec-67, S.A.S. Nagar, Punjab, 160062, India; Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research (NIPER), Sec-67, S.A.S. Nagar, Punjab, 160062, India.

作者： Vikram,Kaithwas ^[1] ; Chander Parkash,Dora ^[1] ; Varun,Kushwah ^[2] ; Sanyog,Jain ^[3]

作者单位： Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sec-67, S.A.S. Nagar, Punjab, 160062, India; Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research (NIPER), Sec-67, S.A.S. Nagar, Punjab, 160062, India. ^[1] Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sec-67, S.A.S. Nagar, Punjab, 160062, India. ^[2] Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sec-67, S.A.S. Nagar, Punjab, 160062, India. Electronic address: sanyogjain@niper.ac.in. ^[3]

关键词 Bioavailability Box-Behnken design Caco-2 cells Nanostructured lipid carrier (NLC)Olmesartan medoxomil